238 related articles for article (PubMed ID: 12750918)
41. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
McColl E; Junghard O; Wiklund I; Revicki DA
Am J Gastroenterol; 2005 Jan; 100(1):11-8. PubMed ID: 15654774
[TBL] [Abstract][Full Text] [Related]
42. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study.
Kawamura O; Aslam M; Rittmann T; Hofmann C; Shaker R
Am J Gastroenterol; 2004 Jun; 99(6):1000-10. PubMed ID: 15180717
[TBL] [Abstract][Full Text] [Related]
43. [Globus pharyngis and gastroesophageal equivalents].
Walther EK; Schmidt C
Laryngorhinootologie; 1997 Apr; 76(4):225-8. PubMed ID: 9264596
[TBL] [Abstract][Full Text] [Related]
44. Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy).
DeVault KR
Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):289-306. PubMed ID: 15722242
[TBL] [Abstract][Full Text] [Related]
45. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.
Ferrari M; Benini L; Brotto E; Locatelli F; De Iorio F; Bonella F; Tacchella N; Corradini G; Lo Cascio V; Vantini I
Scand J Gastroenterol; 2007 Mar; 42(3):299-307. PubMed ID: 17354108
[TBL] [Abstract][Full Text] [Related]
46. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms.
Blonski WC; Shih GL; Brensinger CM; Katzka DA; Metz DC
Scand J Gastroenterol; 2006 Apr; 41(4):382-9. PubMed ID: 16635904
[TBL] [Abstract][Full Text] [Related]
48. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
49. Glossal palpation of the eustachian tube cushion: an unusual cause of globus sensation.
Motamed M; Murty GE
Int J Clin Pract; 2001; 55(1):68. PubMed ID: 11219324
[TBL] [Abstract][Full Text] [Related]
50. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
Xue Y; Zhou LY; Lin SR
Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
[TBL] [Abstract][Full Text] [Related]
51. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
Weigt J; Mönkemüller K; Peitz U; Malfertheiner P
Dig Dis; 2007; 25(3):179-82. PubMed ID: 17827936
[TBL] [Abstract][Full Text] [Related]
52. Globus sensation and increased upper esophageal sphincter pressure with distal esophageal acid perfusion.
Tokashiki R; Funato N; Suzuki M
Eur Arch Otorhinolaryngol; 2010 May; 267(5):737-41. PubMed ID: 19882344
[TBL] [Abstract][Full Text] [Related]
53. A double-blind controlled study of the efficacy of cimetidine in the treatment of the cervical symptoms of gastroesophageal reflux.
Kibblewhite DJ; Morrison MD
J Otolaryngol; 1990 Apr; 19(2):103-9. PubMed ID: 2190005
[TBL] [Abstract][Full Text] [Related]
54. Transition zone defect associated with the response to proton pump inhibitor treatment in patients with globus sensation.
Han MS; Lee H; Jo JH; Cho IR; Park JC; Shin SK; Lee SK; Lee YC
J Gastroenterol Hepatol; 2013 Jun; 28(6):954-62. PubMed ID: 23425059
[TBL] [Abstract][Full Text] [Related]
55. [Relationship between globus sensation and esophageal clearance abnormalities in an elderly group].
Sugiura M; Ohmae Y; Mogitate M; Kimura Y; Makino N; Kato T
Nihon Jibiinkoka Gakkai Kaiho; 2006 Jun; 109(6):524-9. PubMed ID: 16838674
[TBL] [Abstract][Full Text] [Related]
56. Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
Baron TH; Richter JE; Singh S; Tennyson GS; Andres JM
Am J Gastroenterol; 1993 Feb; 88(2):289-92. PubMed ID: 8424436
[TBL] [Abstract][Full Text] [Related]
57. Otolaryngologic manifestations of gastroesophageal reflux.
Gaynor EB
Am J Gastroenterol; 1991 Jul; 86(7):801-8. PubMed ID: 2058616
[TBL] [Abstract][Full Text] [Related]
58. [Nocturnal gastroesophageal reflux as a cause of refractory chronic laryngitis--pathophysiology and management].
Konermann M; Radü B; Liebetrau M; Rawert B; Heimbucher J; Sanner BM
Wien Med Wochenschr; 1999; 151(5-6):142-6. PubMed ID: 11315414
[TBL] [Abstract][Full Text] [Related]
59. Clinical approach to the dysphagic patient.
Halama AR
Acta Otorhinolaryngol Belg; 1994; 48(2):119-26. PubMed ID: 8209674
[TBL] [Abstract][Full Text] [Related]
60. [Dynamics of inflammatory periodontal diseases under the influence of gastroesophageal reflux disease therapy].
Dzhamaldinova TD
Eksp Klin Gastroenterol; 2010; (8):46-51. PubMed ID: 21268326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
